|
AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children
Open Letter to NIMH re Prozac & Concealed Suicide Attempts
Open Letter to Officials at NIMH
AHRP Briefing 2/2/04: Scientists present suicide evidence
Conflicts of Interest policy – New York Times
Phase I Drug Trials Used Foster Care children in Violation of 45 CFR 46.409 and 21 CFR 50.56
AHRP Testimonies re: Fatal ARDS lung experiment
AHRP Comments: DHHS COI Guidance for Human Subject Protection
Children are Humans: Don’t Sacrifice their Rights, Dignity & Welfare
“Should the EPA Accept Human Pesticide Experiments?”, testimony by Vera Sharav before Committee of The National Academies of Science
AHRP Comments on Smallpox Vaccine Testing on Children 2 to 5 Years of Age
AHRP Press Release Children Policy Recommendations
AHRP Replies to OHRP Response re Surrogate Consent.
AHRP Comments Re: DHHS Notice of Proposed Recommendation Regarding Support of Research Protocol: “Precursors to Diabetes in Japanese American Youth“
Media interviews Dr. Meryl Nass re: anthrax vaccine and anthrax attacks
Critique: U.S. to Vaccinate 500,000 Workers Against Smallpox (7/7/02)
Memorandum in opposition to California AB 2328
“Conflicts of Interest In Clinical Trials”, a presentation by Vera Hassner Sharav before the U.S. Army Medical Department and Henry M. Jackson Foundation for Advancement of Military Medicine
Congressional Testimony re: Protecting Children in Research
more…
Time for a Drug Test Registry: Marcia Angell
Dr. Loren Mosher, 1933 – 2004
Cong Hinchey Re: Drug Co. Influence on FDA
FDA Squelches an Article Re Safety Of Device to Repair Artery
FDA Failed to Enforce Law re Test Data Disclosure
Pharma Influence: Penn Whistleblower Lawsuit – Medicare Chief Lied
Scientists Decode Secret of NIH Grants
NIH Under Fire: Longtime Favorite of Congress
Bush Plans to Screen Whole US Population for Mental Illness
More than 100 gov officials represented industry
No evidence that screening reduces suicide
Evidence base: rock of certainty or shifting sands?
Doctors Without Borders: Why you can’t trust medical journals
FDA Bad Faith – Daniel Troy’s pre-emption defense
Ethics Policy Announced for NIH Officials – LAT
Drug Companies and Research at NIH
FDA Advisor: “Ignore breast implant vote“
FDA approves Paxil for Premenstrual cramps
Fast for Freedom: A debate (of sorts) about scientific evidence
Lawsuit: ALLHAT Hypertension research death of human subject
Cholesterol Myths Debunked – Bad News for Statin Drug manufacturers
Greatest Experiment Ever Performed: exploding the Estrogen Myth
Congressional Investigation of NIH: Cash Gifts From Grantees
NHLBI director Dr. Lenfant is Retiring
Psychiatry and Preschoolers
Cost and Consequence: drug “cocktails” deplete Medicaid – Globe
Time to put drug giants on trial – Scotsman (UK)
GlascoSmithKline PAXIL Warning letter to Healthcare Professionals
Don’t Medicate Away Student Angst – Chronicle Higher Ed
view infomail archive
|
Featured News
Safety of Depression’s ‘Wonder Drugs’ Investigated After a Decade of Lies, Deception and Cover-up
NEW: AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children
Mosholder Report: Suicidality in Pediatric Clinical Trials
NYS Attorney General: Suit against GlaxoSmithKline
GSK Internal Memo
Congressional Investigations
Analysis of Prozac/Paxil/Zoloft use in US, 1988-2002 (pdf)
US Paxil Suicide Calculations, 1993-2002
FDA Orders Black Box Warnings – Suicide risk
Psychiatry on the Ropes–WP / Evidence-based Psychiatry
BBC – Taken on Trust – 13 years-Medical Deception
Will Cong Committee Ask FDA Tough Questions?
Black Box Warnings for Antidepressants – What’s Next?
FDA Forced Wyeth to Remove Warning from Effexor
Spitzer Expands Probe / FDA analysis: SSRI Risks to Kids
FDA Approves Cymbalta Despite Risk of Suicide
Safety Hearings-Sept-Congress/ Lilly Plans to Disclose
Janssen Admits Hiding Risperdal Risks / TMAP & Illinois Mental Health Screening
Hearing on Antidepressants Canceled – Washington Post
Greenwood offered job / drops Cong. Pharma hearing
Cong. Hearing: What did drug companies & FDA hide?
NYS AG Expands Pharmaceutical probe
Effexor warnings added: neonatal effects and suicidality
Forest Labs Admits Data Concealment – Cong. Probe Expands
HMO physician applauds Spitzer’s focus on information bias
Antidepressant drug induced Suicides: “Iceberg effect”
Glaxo Faces criminal action in UK over “suicide” pills
NY Times Editorial: When Drug Companies Hide Data
Australian Judge blames Paxil & Effexor
FDA role in suppressing damaging data – WSJ
Bristol Myers Squibb Takes Serzone off the market
Prescriptions for antidepressant declined 10%
Recycled drugs: failed antidepressants
Unpublished Trials Suggest Most SSRIs Unsuitable for Children
Expert FDA Report: SSRI Suicide risk
Rate of Preschool Kids Prescribed Antidepressants Skyrockets
Cong & White House must remedy a prescription for danger
Antidepressant Controversy: Media Conflicts of Interest
FDA Asks drug companies to add Cautions on labels
Healy letter to FDA: suicidal evidence not addressed by FDA
UK MP Accuses Drugs Giant of ‘Voodoo Medicine’
What GSK really thinks about Paxil for Children
GlaxoSmithKline CEO: “We had to absorb a number of hits”
Lilly duloxetine drug trial–19 Quit after a suicide
Healthy 19 year old volunteer suicides at Eli Lilly laboratory
Prescription for Suicide? Time Magazine
Advisory Committee tells FDA: strengthen SSRI warnings
Drug report barred by FDA Scientist links antidepressants to suicide in kids
Antidepressant Makers Withhold Data on Children
ACNP Summary Report Criticized as “Junk Science”
UK doctors told: No Prozac for kids; No Prozac for PMDD
Medscape Cites AHRP Concerns Re: New Law
ABCNEWS.com: Worried About Antidepressants? E-Mail Us
Analysis of paroxetine Yellow Card adverse drug reaction reports (Seroxat/Paxil)
UK to crack down further on antidepressants given out ‘like sweets’
UK Gov’t Document – New SSRI Warnings for Children
UK issues ban on Effexor for children
Wyeth Pharma Warns Doctors Against Rx Effexor to Kids
Connecticut Dept of Children & Families Bans Paxil
74% children prescribed SSRI suffer adverse effects
SSRI Risks: New Data or Renewed Scrutiny? – David Healy, MD
Publication Bias – Patients Beware
Debate Resumes on the Safety of Depression’s Wonder Drugs
GlascoSmithKline Paxil Warning letter to UK Healthcare Professionals
UK Government Bans Paxil for children
Evidence of Suicide Risk & Severe Drug Withdrawal / Dependency
New Presentations, Publications, and Testimonies
The Impact of the FDA Modernization Act – Vera Sharav article
Best Pharmaceuticals for Children’s Act of 2002 – AHRP Comments
Broken Brains or Flawed Studies? – Dr. Cohen & Dr. Leo
Children in Clinical Research: A Conflict of Moral Values – Vera Sharav
AHRP Letter in NEJM re ARDS Investigation
Interview with Dr. Loren Mosher – San Diego Reader
AHRP Testimonies re: Fatal ARDS lung experiment
AHRP Children Policy Recommendations
Why did OHRP SHRED informed consent documents
China Daily update: Harvard genetic research in rural China
China Daily challenges US genetic experiments on poor farmers
OHRP Found NHLBI / ARDS Lung Experiments Violated Informed Consent
Research dispute prompts patient-trials debate – Seattle Times
OHRP Letter to ARDSNetwork re: Investigation of ARDS Study
EPA Opens the Door to Testing Bug Killers on People: Spoon-Feeding Poison Artificial Heart experiment without informed consent?
Research at US Veterans Hospitals Nationwide Under Investigation – NYT
Anthrax Vaccine Consent Form / Should You Roll Up Your Sleeves – WSJ
AHRP is a national network of lay people and professionals dedicated to advancing responsible and ethical medical research practices, to ensure that the human rights, dignity and welfare of human subjects are protected, and to minimize the risks associated with such endeavors.
|
